Laddar...
Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
Oral fostamatinib is an orally administered small molecule spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adults with chronic immune thrombocytopenia (ITP) who have an inadequate response to a previous treatment. Fostamatinib has a unique mechanism of action, whereby its active...
Sparad:
| I publikationen: | Drugs Ther Perspect |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6223701/ https://ncbi.nlm.nih.gov/pubmed/30459507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40267-018-0551-x |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|